PRECISIONxtract Launches OncoGenius, Empowering Oncology Brands with New Insights from Provider-level Data
Recent acquisition of veteran pharmaceutical market consultancy Oncology Reimbursement Management propels and further elevates Precision’s oncology commercialization solutions
INDIANAPOLIS, IN – March 9, 2022 – PRECISIONxtract, a Precision Value & Health team, today announced the launch of OncoGenius, a new digital data and analytic-based solution that provides life science company leaders access to third-party information about oncology provider drug preferences and management. The launch was facilitated by the acquisition earlier this year of Oncology Reimbursement Management (ORM), a specialty consulting and research services company to the oncology pharmaceutical market. Combining ORM’s veteran expertise and depth of market research data with PRECISIONxtract’s proven ability to transform data into products, OncoGenius delivers actionable insights and further expands Precision’s leadership in accelerating the value that life science companies can realize from data…
Syndicated Reports
In-depth, multi-client reports that provide important perspectives of the oncology landscape.
- Oncology Account Manager Report: Measures the effectiveness and performance of Oncology Account Managers across 22 leading pharmaceutical and biotech companies; respondents include CAC members, state society leaders and payer medical and pharmacy directors
- Institutional Pathway Report: Includes 70+ institutions with outpatient cancer services, focusing on NCCN, NCI-designated cancer centers, IDNs, ACOs and additional academic and community institutions (Published bi-annually)
- Oncology Outpatient Marketplace Management Report: Includes 70 institutions and 25 large community-based practices with outpatient cancer services and focuses on cancer drug treatment controls and treatment decision systems as well as change-drivers
Consulting
Customized, client-specific projects for pre- and post-launch phases to support mobilization and access.
- Landscape assessment
- Market access strategy
- Pricing and distribution solutions
- Launch mobilization
- Contracting and rebating
- Value propositions
- Formulary access and utilization management
Research
Thoughtful, targeted investigations designed to uncover actionable insights.
- Qualitative research: Customized surveys to address key business questions
- Quantitative research: In-depth interviews to identify actionable insights
- Recruiting: Identifying top-tier talent for a wide range of managed care roles
Advisory Board Management
Facilitation that bring together leading minds in oncology.
- Advisor recruiting
- Agenda development
- Moderating
- Summary reporting
Our Clients
Whether determining the appropriate outcome metrics and standards for future access/reimbursement payer decisions or preparing for generic competition, ORM can help guide strategic choices within these companies to achieve revenue goals.
Payers
ORM provides a perspective on the oncology marketplace that is often difficult for payers to acquire. Our neutral point of view regarding various key stakeholders can better inform some payer decisions by helping them understand who prominent influencers are and how they operate.
GPOs and Distributors
Pharmaceutical companies often underutilize the GPO as a promotional channel. ORM facilitates the development of effective partnerships between distributors, their GPO membership and pharmaceutical companies to create synergy among various promotional initiatives within this channel.
Professional Associations
Professional associations play a critical role in aligning key oncology stakeholders at both the national and regional levels. ORM helps these organizations develop and implement strategies that not only achieve their goals for oncologists, but also support the best interests of payers, pharmaceutical companies and other oncology key players.
Oncologists
While ORM does not provide reimbursement services for individual practices (coverage, coding and billing), we do deliver data, analyses and recommendations to groups of practices that seek to improve how they work with other key stakeholders, such as pharmaceutical companies, payers and distributors.
